NCT02921555 Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis Status TERMINATED Phase PHASE4
NCT02914717 The Belgian SMART Study Evaluating the Use of Golimumab for Ulcerative Colitis Status COMPLETED Phase N/A
NCT02914535 Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02914522 Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT02913508 Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease Status WITHDRAWN Phase PHASE2
NCT02895100 Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT02888379 Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT02878083 Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT) Status TERMINATED Phase NA
NCT02868398 Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With Infliximab Status COMPLETED Phase N/A
NCT02864264 Single Ascending Dose and Multiple Ascending Dose Study in Healthy Participants and Proof of Mechanism Study in Patients With Ulcerative Colitis Status TERMINATED Phase PHASE1
NCT02862132 Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases Status COMPLETED Phase NA
NCT02852850 In Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative Colitis Status UNKNOWN Phase N/A
NCT02849951 A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC) Status TERMINATED Phase PHASE3
NCT02846961 Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT02822352 RCT: HDWL vs Virtual Chromoendoscopy in the Detection of Intraepithelial Neoplasia in Longstanding Colitis Status COMPLETED Phase NA
NCT02818543 Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT02808780 An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase N/A